Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 18, 1996

View Archived Issues

Beta-blocker treatment reduces fatal post-surgical heart attack

Novel GABA uptake inhibitors from Novo Nordisk

Dainippon describes agents that act selectively on peripheral benzodiazepine receptors

Antiangiogenic compounds described by Taiho

Sandoz reports on tetraline derivatives for neurological disorders

Mercian discloses novel antitumor anthracycline antibiotics

Carbapenem esters revealed by SKB

Company Profile: Arris

Company Profile: Bone Care International

ML-3000 progresses through the pipeline

Piliel enters pivotal trials in Europe

Pamidronate effective against skeletal complications in breast cancer patients

Troglitazone hypotensive, hypoglycemic activities established in preclinical model

Corvas and Schering-Plough expand antithrombotic collaboration

Positive results reported for group A Streptococcus vaccine

Beacon obtains rights to Centocor tumor markers

Biovail grants another license for diltiazem product

New alopecia Rx tested in patients

Anti-L-selectin aptamers demonstrate efficacy in animals

Molecular Biosystems and Mallinckrodt expand contrast agent agreement

Shaman and Ono expand diabetes collaboration

GLA effective in treating active rheumatoid arthritis

Sankyo product pipeline in review

Chemopreventive effects of Targretin in breast cancer

Ciba/Sandoz merger approved

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...